J&J’s Covid Vaccine Gets Another $1 Billion Funding Boost
The trial for the Johnson & Johnson COVID-19 vaccine has been temporarily halted after a participant became ill, AFP reported on Tuesday, 13 October. Photo used for representational purposes only.

J&J’s Covid Vaccine Gets Another $1 Billion Funding Boost

(Bloomberg) --
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.